Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data

Basit Öğe Kaydı
dc.authorwosidCakir, Necati/AAG-7283-2019
dc.contributor.authorPamuk, O. N.
dc.contributor.authorDonmez, S.
dc.contributor.authorKarahan, B.
dc.contributor.authorPamuk, G. E.
dc.contributor.authorCakir, N.
dc.date.accessioned2024-06-12T11:02:37Z
dc.date.available2024-06-12T11:02:37Z
dc.date.issued2009
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective. In this study, we evaluated clinical and epidemiologic features of our giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) patients. Methods. Me retrospectively recorded down the general features of patients with GCA and PMR diagnosed at our center within the last 6 years. The incidence rates per 100000 aged. >= 50 were calculated. In addition, we reported the frequencies of GCA/PMR in our previous epidemiologic study. Results. Nineteen patients were diagnosed with GCA (10F, 9M) and 53 with isolated PMR (39F 14M). The annual incidence for GCA in subjects >= 50 years old was 1.13/100000, and for PMR it was 3.15/100000. The incidence of GCA and PMR in females were, respectively, 1.14/100000 and 4.48/100000. In males, the incidences of GCA and PMR were, respectively, calculated as 1.1/100000 and 1.72/100000. In our population-based study, the prevalences of GCA and PMR (>= 50 ages) were estimated as 20/100000. Fourteen (73.7%) GCA patients had symptoms of PMR. Two patients had developed unilateral and one patient bilateral permanent visual loss. Initial ESR was lower than 40 mm/hr in one GCA patient (5.3%) and in 6 PMR patients (11.3%). The median duration of follow-up(l) was 16 months in GCA; and 8 months in PMR patients. One patient with PMR and another patient with GCA had lung cancer. One PMR patient had myelodysplastic syndrome. During follow-up, 4 patients with GCA died. Conclusions. Me detected a lower frequency GCA/PMR in our center in northwestern Turkey than in Scandinavian and southern European countries.en_US
dc.identifier.endpage833en_US
dc.identifier.issn0392-856X
dc.identifier.issn1593-098X
dc.identifier.issue5en_US
dc.identifier.pmid19917168en_US
dc.identifier.scopus2-s2.0-72949111368en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage830en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21360
dc.identifier.volume27en_US
dc.identifier.wosWOS:000272278400152en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherClinical & Exper Rheumatologyen_US
dc.relation.ispartofClinical And Experimental Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGiant Cell Arteritisen_US
dc.subjectPolymyalgia Rheumaticaen_US
dc.subjectEpidemiologyen_US
dc.subjectPrevalenceen_US
dc.subjectIncidenceen_US
dc.subjectTemporal Arteritisen_US
dc.subjectOlmsted Countyen_US
dc.subjectSpainen_US
dc.subjectMinnesotaen_US
dc.subjectSpectrumen_US
dc.subjectClassificationen_US
dc.subjectJerusalemen_US
dc.subjectDiseaseen_US
dc.subject10-Yearen_US
dc.titleGiant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological dataen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu